{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:35:21Z","timestamp":1776335721938,"version":"3.51.2"},"reference-count":120,"publisher":"European Respiratory Society (ERS)","issue":"159","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,6,12]]},"published-print":{"date-parts":[[2021,3,31]]},"abstract":"<jats:p>Pleural infection and malignancy are among the most common causes of pleural disease and form the mainstay of pleural practice. There has been significant research and increase in scientific understanding in these areas in the past decade. With regard to pleural infection, the rising incidence remains worrying. An increased awareness allowing earlier diagnosis, earlier escalation of therapy and the use of validated risk stratification measures may improve outcomes. In pleural malignancy, research has enabled clinicians to streamline patient pathways with focus on reducing time to diagnosis, definitive management of malignant pleural effusion and achieving these with the minimum number of pleural interventions. Trials comparing treatment modalities of malignant pleural effusion continue to highlight the importance of patient choice in clinical decision-making. This article aims to summarise some of the most recent literature informing current practice in these two areas.<\/jats:p>","DOI":"10.1183\/16000617.0002-2020","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T16:28:42Z","timestamp":1614702522000},"page":"200002","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Advances in pleural infection and malignancy"],"prefix":"10.1183","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-3934","authenticated-orcid":false,"given":"Eihab O.","family":"Bedawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Guinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najiib M.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3988-1792","authenticated-orcid":false,"given":"Philippe","family":"Astoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"2024102403505682000_30.159.200002.1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.chest.2015.12.027","article-title":"Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia","volume":"149","author":"Dean","year":"2016","journal-title":"Chest"},{"key":"2024102403505682000_30.159.200002.2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.156406"},{"key":"2024102403505682000_30.159.200002.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.09.038"},{"key":"2024102403505682000_30.159.200002.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir354"},{"key":"2024102403505682000_30.159.200002.5","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01200-09"},{"key":"2024102403505682000_30.159.200002.6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ofid\/ofw172.637","article-title":"Trends in pediatric pneumococcal pleural empyema following pneumococcal conjugate 13-valent vaccination: 10 years of active surveillance in a Mexican hospital","volume":"3;","author":"Chacon-Cruz","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2024102403505682000_30.159.200002.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204457.79"},{"key":"2024102403505682000_30.159.200002.8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.21037\/jtd.2018.12.101","article-title":"Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases","volume":"11","author":"Fitzgerald","year":"2019","journal-title":"J Thorac Dis"},{"key":"2024102403505682000_30.159.200002.9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12931-017-0501-5","article-title":"The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection","volume":"18","author":"Dixon","year":"2017","journal-title":"Respir Res"},{"key":"2024102403505682000_30.159.200002.10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MCP.0000000000000481","article-title":"The role of procalcitonin in the management of pleural infection","volume":"24","author":"de Fonseka","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"2024102403505682000_30.159.200002.11","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu104"},{"key":"2024102403505682000_30.159.200002.12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cyto.2013.04.017","article-title":"Interleukin-18 is up-regulated in infectious pleural effusions","volume":"63","author":"Rovina","year":"2013","journal-title":"Cytokine"},{"key":"2024102403505682000_30.159.200002.13","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1038\/s41598-017-04189-4","article-title":"Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"2024102403505682000_30.159.200002.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2012.11.002"},{"key":"2024102403505682000_30.159.200002.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00197208"},{"key":"2024102403505682000_30.159.200002.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200601-074OC"},{"key":"2024102403505682000_30.159.200002.17","doi-asserted-by":"crossref","first-page":"1900542","DOI":"10.1183\/13993003.00542-2019","article-title":"The microbiology of pleural infection in adults: a systematic review","volume":"54","author":"Hassan","year":"2019","journal-title":"Eur Respir J"},{"key":"2024102403505682000_30.159.200002.18","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.157842"},{"key":"2024102403505682000_30.159.200002.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042473"},{"key":"2024102403505682000_30.159.200002.20","doi-asserted-by":"publisher","DOI":"10.1054\/modi.2001.29158"},{"key":"2024102403505682000_30.159.200002.21","first-page":"123","article-title":"[16S rRNA gene sequencing for pathogen identification from clinical specimens]","volume":"88","author":"Lu","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2024102403505682000_30.159.200002.22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.chest.2018.02.031","article-title":"A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the AUDIO study)","volume":"154","author":"Psallidas","year":"2018","journal-title":"Chest"},{"key":"2024102403505682000_30.159.200002.23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01228-07"},{"key":"2024102403505682000_30.159.200002.24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17476348.2019.1578212","article-title":"Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics","volume":"13","author":"Bedawi","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2024102403505682000_30.159.200002.25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1044"},{"issue":"Suppl. 2","key":"2024102403505682000_30.159.200002.26","first-page":"ii41","article-title":"Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010","volume":"65: ,","author":"Davies","year":"2010","journal-title":"Thorax"},{"key":"2024102403505682000_30.159.200002.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740"},{"key":"2024102403505682000_30.159.200002.28","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00084-2019"},{"key":"2024102403505682000_30.159.200002.29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1513\/AnnalsATS.201608-594BC","article-title":"Safety and efficacy of tissue plasminogen activator and DNase for complicated pleural effusions secondary to abdominal pathology","volume":"14","author":"Majid","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403505682000_30.159.200002.30","first-page":"999","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection","volume":"7","author":"Piccolo","year":"2015","journal-title":"J Thorac Dis"},{"key":"2024102403505682000_30.159.200002.31","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000334"},{"key":"2024102403505682000_30.159.200002.32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project","volume":"14","author":"Popowicz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403505682000_30.159.200002.33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000443334","article-title":"Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease","volume":"91","author":"Mehta","year":"2016","journal-title":"Respiration"},{"key":"2024102403505682000_30.159.200002.34","doi-asserted-by":"crossref","first-page":"9796768","DOI":"10.1155\/2016\/9796768","article-title":"Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections","volume":"2016","author":"McClune","year":"2016","journal-title":"Can Respir J"},{"key":"2024102403505682000_30.159.200002.35","doi-asserted-by":"crossref","unstructured":"Cameron R , Davies HR . Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2008: CD002312.","DOI":"10.1002\/14651858.CD002312.pub3"},{"key":"2024102403505682000_30.159.200002.36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-173"},{"key":"2024102403505682000_30.159.200002.37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1577"},{"key":"2024102403505682000_30.159.200002.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000440"},{"key":"2024102403505682000_30.159.200002.39","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00147214"},{"key":"2024102403505682000_30.159.200002.40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MCP.0000000000000171","article-title":"Repeated therapeutic thoracentesis to manage complicated parapneumonic effusions","volume":"21","author":"Jouneau","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"2024102403505682000_30.159.200002.41","doi-asserted-by":"crossref","first-page":"e84788","DOI":"10.1371\/journal.pone.0084788","article-title":"Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion","volume":"9","author":"Letheulle","year":"2014","journal-title":"PLoS One"},{"key":"2024102403505682000_30.159.200002.42","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.5.3303"},{"key":"2024102403505682000_30.159.200002.43","first-page":"124","article-title":"Practical management of pleural empyema","volume":"73","author":"Tassi","year":"2010","journal-title":"Monaldi Arch Chest Dis"},{"key":"2024102403505682000_30.159.200002.44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12890-018-0745-y","article-title":"Role of medical thoracoscopy in the management of multiloculated empyema","volume":"18","author":"Sumalani","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2024102403505682000_30.159.200002.45","doi-asserted-by":"publisher","DOI":"10.1159\/000339414"},{"key":"2024102403505682000_30.159.200002.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030074"},{"key":"2024102403505682000_30.159.200002.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.09.021"},{"key":"2024102403505682000_30.159.200002.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.12.031"},{"key":"2024102403505682000_30.159.200002.49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12890-018-0726-1","article-title":"Pleural infection: a retrospective study of clinical outcome and the correlation to known etiology, co-morbidity and treatment factors","volume":"18","author":"Meyer","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2024102403505682000_30.159.200002.50","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00541-2019"},{"key":"2024102403505682000_30.159.200002.51","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01550-2018"},{"key":"2024102403505682000_30.159.200002.52","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1558"},{"key":"2024102403505682000_30.159.200002.53","doi-asserted-by":"crossref","first-page":"e127470","DOI":"10.1172\/jci.insight.127470","article-title":"Phase I trial of the single-chain urokinase intrapleural LTI-01 in complicated parapneumonic effusions or empyema","volume":"4","author":"Beckert","year":"2019","journal-title":"JCI Insight"},{"key":"2024102403505682000_30.159.200002.54","unstructured":"Boylan A , Broaddus V . Tumours of the pleura. In: Mason RJ , Murray JF , Nadel JA , et al. , eds. Murray and Nadel's Textbook of Respiratory Medicine . 4th Edn. Philadelphia, Elsevier, 2005."},{"key":"2024102403505682000_30.159.200002.55","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205285"},{"key":"2024102403505682000_30.159.200002.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2013.11.007"},{"key":"2024102403505682000_30.159.200002.57","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10081907"},{"key":"2024102403505682000_30.159.200002.58","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12496"},{"key":"2024102403505682000_30.159.200002.59","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"key":"2024102403505682000_30.159.200002.60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000485934","article-title":"Procedures performed during hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample","volume":"95","author":"Fortin","year":"2018","journal-title":"Respiration Dis"},{"key":"2024102403505682000_30.159.200002.61","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209340"},{"key":"2024102403505682000_30.159.200002.62","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.100545"},{"key":"2024102403505682000_30.159.200002.63","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.548"},{"key":"2024102403505682000_30.159.200002.64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02018-2018"},{"key":"2024102403505682000_30.159.200002.65","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2876"},{"key":"2024102403505682000_30.159.200002.66","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/resp.13681","article-title":"Inter-observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion","volume":"25","author":"Martin","year":"2020","journal-title":"Respirology"},{"key":"2024102403505682000_30.159.200002.67","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.154.3.2106209"},{"key":"2024102403505682000_30.159.200002.68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1378\/chest.14-0013","article-title":"Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions","volume":"147","author":"Porcel","year":"2015","journal-title":"Chest"},{"key":"2024102403505682000_30.159.200002.69","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0820"},{"key":"2024102403505682000_30.159.200002.70","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.chest.2019.10.025","article-title":"The impact of gravity vs suction-driven therapeutic thoracentesis on pressure-related complications: the GRAVITAS multicenter randomized controlled trial","volume":"157","author":"Lentz","year":"2020","journal-title":"Chest"},{"key":"2024102403505682000_30.159.200002.71","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000174"},{"key":"2024102403505682000_30.159.200002.72","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(18)30421-1","article-title":"Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial","volume":"7","author":"Lentz","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102403505682000_30.159.200002.73","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01254-2018"},{"key":"2024102403505682000_30.159.200002.74","first-page":"1169","article-title":"Molecular profiling of malignant pleural effusion in metastatic non-small-cell lung carcinoma. The effect of preanalytical factors","volume":"14","author":"Carter","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403505682000_30.159.200002.75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/LBR.0000000000000534","article-title":"Yield of malignant pleural effusion for detection of oncogenic driver mutations in lung adenocarcinoma","volume":"26","author":"DeMaio","year":"2019","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2024102403505682000_30.159.200002.76","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/PAI.0000000000000543","article-title":"Comparison of epidermal growth factor receptor gene mutations identified using pleural effusion and primary tumor tissue samples in non-small cell lung cancer","volume":"26","author":"Liu","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2024102403505682000_30.159.200002.77","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4143\/crt.2017.378","article-title":"EGFR mutation status in lung adenocarcinoma-associated malignant pleural effusion and efficacy of EGFR tyrosine kinase inhibitors","volume":"50","author":"Yang","year":"2018","journal-title":"Cancer Res Treat"},{"key":"2024102403505682000_30.159.200002.78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613493"},{"key":"2024102403505682000_30.159.200002.79","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"2024102403505682000_30.159.200002.80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"2024102403505682000_30.159.200002.81","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/resp.13614","article-title":"PD-L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC","volume":"24","author":"Grosu","year":"2019","journal-title":"Respirology"},{"key":"2024102403505682000_30.159.200002.82","doi-asserted-by":"crossref","first-page":"11206","DOI":"10.1038\/s41598-018-29156-5","article-title":"PD-L1 expression in pleural effusions of pulmonary adenocarcinoma and survival prediction: a controlled study by pleural biopsy","volume":"8","author":"Xu","year":"2018","journal-title":"Sci Rep"},{"key":"2024102403505682000_30.159.200002.83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/cncy.21937","article-title":"PD-L1 expression in non-small cell lung carcinoma: comparison among cytology, small biopsy, and surgical resection specimens","volume":"125","author":"Heymann","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"2024102403505682000_30.159.200002.84","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00349-2018"},{"key":"2024102403505682000_30.159.200002.85","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3282fe9a04"},{"key":"2024102403505682000_30.159.200002.86","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13079-6"},{"key":"2024102403505682000_30.159.200002.87","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2017-000270"},{"key":"2024102403505682000_30.159.200002.88","first-page":"519","article-title":"Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists","volume":"71","author":"Diacon","year":"2004","journal-title":"Respir Int Rev Thorac Dis"},{"key":"2024102403505682000_30.159.200002.89","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.3.828"},{"key":"2024102403505682000_30.159.200002.90","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.137018"},{"key":"2024102403505682000_30.159.200002.91","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-4-271"},{"key":"2024102403505682000_30.159.200002.92","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23034"},{"key":"2024102403505682000_30.159.200002.93","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00173-X"},{"key":"2024102403505682000_30.159.200002.94","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-0034-1395796","article-title":"Medical thoracoscopy","volume":"35","author":"Skalski","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102403505682000_30.159.200002.95","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02738"},{"key":"2024102403505682000_30.159.200002.96","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12441"},{"key":"2024102403505682000_30.159.200002.97","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136994"},{"key":"2024102403505682000_30.159.200002.98","first-page":"91","article-title":"Mechanisms of pleurodesis","volume":"83","author":"Rodriguez-Panadero","year":"2012","journal-title":"Respir Int Rev Thorac Dis"},{"key":"2024102403505682000_30.159.200002.99","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.909"},{"key":"2024102403505682000_30.159.200002.100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1843.2001.00327.x"},{"key":"2024102403505682000_30.159.200002.101","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lungcan.2019.09.003","article-title":"Survival in patients with malignant pleural effusion undergoing talc pleurodesis","volume":"137","author":"Hassan","year":"2019","journal-title":"Lung Cancer Amst Neth"},{"key":"2024102403505682000_30.159.200002.102","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An Official ATS\/STS\/STR Clinical Practice Guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403505682000_30.159.200002.103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial","volume":"323","author":"Bhatnagar","year":"2019","journal-title":"JAMA"},{"key":"2024102403505682000_30.159.200002.104","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"2016","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102403505682000_30.159.200002.105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087060"},{"key":"2024102403505682000_30.159.200002.106","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-3103"},{"key":"2024102403505682000_30.159.200002.107","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.2.362"},{"key":"2024102403505682000_30.159.200002.108","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M"},{"key":"2024102403505682000_30.159.200002.109","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"2024102403505682000_30.159.200002.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.10.002"},{"key":"2024102403505682000_30.159.200002.111","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5535"},{"key":"2024102403505682000_30.159.200002.112","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403505682000_30.159.200002.113","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102403505682000_30.159.200002.114","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12962"},{"key":"2024102403505682000_30.159.200002.115","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1868"},{"key":"2024102403505682000_30.159.200002.116","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/LBR.0000000000000186","article-title":"Pleuroscopic pleurodesis combined with tunneled pleural catheter for management of malignant pleural effusion: a prospective observational study","volume":"22","author":"BoDNujaoude","year":"2015","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2024102403505682000_30.159.200002.117","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0394"},{"key":"2024102403505682000_30.159.200002.118","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102403505682000_30.159.200002.119","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/01902148.2017.1384865","article-title":"Local and systemic effects of a silver nitrate coated indwelling pleural catheter in an animal model of pleurodesis","volume":"43","author":"Tremblay","year":"2017","journal-title":"Exp Lung Res"},{"key":"2024102403505682000_30.159.200002.120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/rccm.201701-0097LE","article-title":"A novel drug-eluting indwelling pleural catheter for the management of malignant effusions","volume":"197","author":"Bhatnagar","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0002-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:02:32Z","timestamp":1740373352000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0002-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":120,"journal-issue":{"issue":"159","published-online":{"date-parts":[[2021,1,13]]},"published-print":{"date-parts":[[2021,3,31]]}},"alternative-id":["10.1183\/16000617.0002-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0002-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]}}}